6569.TWO · ONYX
Taiwan · RS rating 16 · As of 2026-10-08
| Price | 91.40 TWD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 52 / 18 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 7 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +55.3% |
| Sales growth Q/Q | +13.7% |
| Distance from 52-week high | +31.0% |
| Market cap (USD) | $123.1M |